159 related articles for article (PubMed ID: 31285661)
1. Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
Jalili F; O'Conaill C; Templeton K; Lotocki R; Fischer G; Manning L; Cormier K; Decker K
Curr Oncol; 2019 Jun; 26(3):167-172. PubMed ID: 31285661
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
3. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
4. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
5. Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.
Reiter PL; Shoben AB; McDonough D; Ruffin MT; Steinau M; Unger ER; Paskett ED; Katz ML
Sex Transm Dis; 2019 Mar; 46(3):185-190. PubMed ID: 30461597
[TBL] [Abstract][Full Text] [Related]
6. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
8. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
Meenan RT; Troja C; Buist DSM; Tiro JA; Lin J; Anderson ML; Gao H; Green BB; Winer RL
JAMA Netw Open; 2023 Mar; 6(3):e234052. PubMed ID: 36947040
[TBL] [Abstract][Full Text] [Related]
9. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
[TBL] [Abstract][Full Text] [Related]
10. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.
Tiro JA; Betts AC; Kimbel K; Buist DSM; Mao C; Gao H; Shulman L; Malone C; Beatty T; Lin J; Thayer C; Miglioretti DL; Winer RL
J Womens Health (Larchmt); 2019 Mar; 28(3):384-392. PubMed ID: 30481121
[TBL] [Abstract][Full Text] [Related]
11. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
[TBL] [Abstract][Full Text] [Related]
12. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
[TBL] [Abstract][Full Text] [Related]
13. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model.
Dutton T; Marjoram J; Burgess S; Montgomery L; Vail A; Callan N; Jacob S; Hawkes D; Saville M; Bailey J
BMC Health Serv Res; 2020 May; 20(1):398. PubMed ID: 32393243
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
[TBL] [Abstract][Full Text] [Related]
15. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
Virtanen A; Anttila A; Nieminen P
BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
Carozzi FM; Royder Yanez R; Paganini I; Sani C; Cannistrà S; Matucci M; von Borries S; Traina S
PLoS One; 2024; 19(3):e0292605. PubMed ID: 38451956
[TBL] [Abstract][Full Text] [Related]
17. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
[TBL] [Abstract][Full Text] [Related]
18. HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.
Sultana F; Gertig DM; English DR; Simpson JA; Drennan KT; Wrede CD; Mullins RM; Heley S; Saville M; Brotherton JM
J Med Screen; 2022 Sep; 29(3):185-193. PubMed ID: 35313763
[TBL] [Abstract][Full Text] [Related]
19. [Budget impact of self-testing in the national cervical cancer screening program].
Marchadier A; Leleu H; Barré S
Rev Epidemiol Sante Publique; 2023 Jun; 71(3):101838. PubMed ID: 37062157
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
Lam JU; Rebolj M; Møller Ejegod D; Pedersen H; Rygaard C; Lynge E; Thirstrup Thomsen L; Krüger Kjaer S; Bonde J
Int J Cancer; 2017 May; 140(10):2212-2219. PubMed ID: 28195317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]